Exploring the association of legalisation status of cannabis with problematic cannabis use and impulsivity in the USA

Louise Destrée BPsych (Hons), Danielle Amiet BPsych (Hons), Adrian Carter PhD, Rico Lee PhD, Valentina Lorenzetti PhD, Rebecca Segrave PhD, George Youssef PhD, Nadia Solowij PhD, Murat Yücel PhD

Article Type

Original Research

Published

This study investigated whether the legal status of cannabis in the USA is associated with problematic cannabis use and impulsivity in frequent cannabis users.

Read more

Suvorexant for insomnia in older adults: a perspective review

Rajesh R Tampi, Geetha Manikkara, Silpa Balachandran, Piyush Taparia, Stephanie Hrisko, Shilpa Srinivasan, Deena J Tampi

Article Type

Review

Published

This review identifies published randomized control trials that evaluate the efficacy and tolerability of suvorexant for the treatment of insomnia among older adults.

Read more

Corrigendum: Pharmacoeconomic comparison of aripiprazole once-monthly and paliperidone palmitate from a head-to-head clinical trial in schizophrenia: a US analysis

Christophe Sapin, Ann Hartry, Siddhesh A Kamat, Maud Beillat, Ross A Baker, Anna Eramo

Article Type

Corrigendum

Published

The authors wish to make the following corrections to their article: Sapin C, Hartry A, Kamat SA, Beillat M, Baker RA, Eramo A. Pharmacoeconomic comparison of aripiprazole once-monthly and paliperidone palmitate from a head-to-head clinical trial in schizophrenia: a US analysis. Drugs in Context 2016; 5: 212301. DOI: 10.7573/dic.212301

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.